TABLE 126 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.57% during 2023-2028. Further, with the spread of the COVID-19 pandemic, immediate and long-term consequences have been both for people and health systems worldwide. 13.5 AUTHOR DETAILS. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. 1.2.2 MARKETS COVERED In December 2021, TriNetX LLC announced the launch of Diversity Lens, an analytic feature that enables healthcare and life sciences organizations to make use of real-world data to comprehend and address racial and ethnic differences in clinical trial patient participation. TOP-LEVEL FINDINGS. For instance, in May 2020, PAREXEL International Corporation (U.S.) launched the #KeepingPatientsFirst integrated real-world evidence (RWE) research platform focused on aggregating, analyzing, and predicting real-world COVID-19-related disease progression and outcomes using state-of-the-art machine learning, artificial intelligence, and analytics. TABLE 32 RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) Real-world evidence (RWE) is clinical evidence gathered via RWD analysis on the use and potential benefits or risks of a medical product. Real World Evidence Solutions Market Size And Forecast Real World Evidence Solutions Market size was valued at USD 870.79 Million in 2020 and is projected to reach USD 2463.14 Million by 2028, growing at a CAGR of 13.92% from 2021 to 2028. Because of these benefits, the use of real-world evidence solutions is increasing in drug and medical device R&D activities. A five-year forecast of the market and noted trends. Through this acquisition, the company aimed at helping businesses create resilient and sustainable operations and supply chains.Oct-2019: Parexel entered into a strategic partnership with HealthVerity, Inc., the service provider for rapid creation, exchange, and management of healthcare and consumer data. 11.8.2 STARTING BLOCKS For instance, although payers have started using RWE, they prefer to use randomised clinical trials (RCTs) instead of external observational data to inform drug coverage decisions. The industry insights chapters include value chain analysis, Porters five forces analysis, technology analysis, patent analysis, key conferences and events in 20222023, pricing analysis, and key stakeholders and buying criteria. 10.3 EUROPE "Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes)." 12.1 KEY PLAYERS 5.2.2 RESTRAINTS 6.1.3 RISE IN THE USE OF RWD AND RWE ACROSS THE PHARMACEUTICAL INDUSTRY Zillow has 314 homes for sale in Lake Arrowhead CA. Real-world data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. One of its mandates was for the US FDA to develop a framework to evaluate how data from sources other than clinical trials can be used to support drug approvals. Further understanding of the efficacy and safety of medications for diabetes and certain other diseases for which diabetes can be an underlying causative factor is necessary. TABLE 144 INDIA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 52 LABCORP HOLDINGS: COMPANY SNAPSHOT (2021) 5.2.1.5 Support from regulatory bodies for the use of RWE solutions For instance, in April 2020, ICON plc (Ireland) signed a three-year agreement with Pfizer Inc. (U.S.), under which ICON provides expertise in the planning, execution, management, and conduct of clinical trials. Many medical professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemics spread and create efficient drugs and vaccinations. TABLE 6 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY In 2020, every person generated 1.7 megabytes in just a second. NAND flash manufacturers revenue share worldwide 2010-2022, by quarter, DRAM manufacturers revenue share worldwide 2011-2022, by quarter, Number of data centers worldwide 2022, by country, DRAM manufacturers revenue worldwide 2011-2022, by quarter. TABLE 26 RWE PATIENT-POWERED DISPARATE DATA MARKET, BY COUNTRY, 20202027 (USD MILLION) 2.1 RESEARCH DATA TABLE 61 US: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 48 OPTUM INC.: COMPANY SNAPSHOT (2021) 6.2 Real-World Data Sources Table 4 Indicative List of National Databases in Developed Countries 6.3 Ecosystem Analysis Figure 27 Ecosystem Coverage: Parent Market (Healthcare It Solutions) . 5.2.1.4 Increased R&D spending for the development of new pharmaceutical products and medical devices Real World Data (RWD), patient data that originates from real world settings delivers powerful insights to healthcare stakeholders Podcast Leveraging insights made possible by AI technology, Medical Affairs professionals are fostering better connections with healthcare professionals. 2.1.2.2 Insights from primary experts TABLE 22 CLAIMS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) 6.2 REAL-WORLD DATA SOURCES TABLE 138 CHINA: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) 6.1.4 INTERNAL VS. OUTSOURCED RWE ANALYTICS APPROACH on February 23, 2023 By Marcus Lu Retail Investors' Most Popular Stocks of 2023 (YTD) According to VandaTrack, retail investors are still a force to be reckoned with, adding an average of $1.5 billion each day into U.S. markets. 80% of fortune 2000 companies rely on our research to identify new revenue sources. TABLE 174 ICON PLC. Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Despite these impediments, engineers worldwide are embracing innovative solutions . 11.8.4 DYNAMIC COMPANIES 8.2.1.1 Growing number of clinical trials focused on cancer treatment to drive growth 12.1.20 MEDPACE HOLDINGS INC. Download Report. 12.2.1 HEALTHVERITY INC. FIGURE 23 NUMBER OF CLINICAL TRIALS STARTED DURING 20152020 Click Manage settings for more information and to manage your choices. 6.4.4 THREAT OF SUBSTITUTES TABLE 127 JAPAN: MACROECONOMIC INDICATORS RWD has been used increasingly to map the progression of the disease and to discover vaccines and immediate treatments. 8.2.2.1 High prevalence of CVD to drive growth 24*7 real-time access to a vast global inventory of hotel rooms, cars, airlines, buses, tours and other travel-related items. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach. TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS - 41) TABLE 123 ASIA PACIFIC: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Business Solutions including all features. TABLE 34 LIST OF PIPELINE DRUGS FOR ONCOLOGY (2018) Coming Soon listings are homes that will soon be on the market. Note 2: Other primaries include sales managers, marketing managers, and product managers. - 81) Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. According to estimates, cancer, obesity, cardiovascular diseases, and diabetes, all of which are on the rise, are responsible for over half of all fatalities from chronic diseases. ET A paid subscription is required for full access. FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD The global Real World Evidence Solutions Market size was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031. In 2021, the real-world datasets segment accounted for the larger share of the overall real-world evidence solutions market. 7.3.1.5.1 Increasing number of disease registries is driving the demand for registry-based data sets in evidence generation 7.3.2.1 Increasing demand for integrated data from multiple sources to drive growth TABLE 87 UK: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) The primary sources from the demand side included Directors, and strategy managers of pharmaceutical and medical device companies, insurance providers, healthcare providers, and department heads. statistic alerts) please log in with your personal account. The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to 2027. The world's patient population is experiencing a rapidly increasing frequency of drug shortages whereby patients cannot get access to the medicines they critically need. Pharmaceutical and biopharmaceutical businesses are choosing fully functional or integrated outsourcing services from the early development phase to the late-stage development phase to meet the requirements for drug development and discovery due to their increasing R&D spending. FIGURE 58 CLINIGEN: COMPANY SNAPSHOT (2021) The oncology segment dominates owing to the rising prevalence of cancer and the increasing number of clinical trials and studies focused on cancer treatment and prevention. With the given market data, MarketsandMarkets offers customizations as per your companys specific needs. TABLE 100 ITALY: MACROECONOMIC INDICATORS the controller uses real-time particle size and moisture content data as well as Fluid Bed Granulation process data to make realtime process control decisions . RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). These variations can affect reimbursement, patient access, and potentially healthcare outcomes across health plans during the pharmaceutical technology assessment (PTA) process. Are you interested in testing our business solutions? 8.2.4.1 Increasing focus on developing innovative products to drive growth 8.6.1 LIMITED VALIDITY OF RANDOMIZED CONTROLLED TRIALS DRIVING THE USE OF RWE SOLUTIONS IN THE SEGMENT TABLE 5 PORTERS FIVE FORCES ANALYSIS 6.7 REGULATORY BODIES, GOVERNMENTS, AND OTHER ORGANIZATIONS TABLE 70 CANADA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 134 CHINA: MACROECONOMIC INDICATORS The major reason for this preference is the presence of multiple standards and methods for analysing real-world clinical experience evidence. FIGURE 13 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes) [Graph]. 9.1 INTRODUCTION Through this acquisition, the company would focus on developing drugs by using data, applying techniques, and identifying a variety of patient populations.Dec-2020: Syneos Health completed the acquisition of Illingworth Research Group, a provider of clinical research home health services. TABLE 31 INTEGRATED DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION), 8 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION (Page No. FIGURE 24 UTILIZATION OF WEARABLES IN CLINICAL TRIALS, BY THERAPEUTIC AREA, 2019 The global data monetization market size was valued at USD 1.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2020 to 2027. Furthermore, it would enable the company to bring new therapies to market by leveraging these studies.Sep-2018: PAREXEL came into partnership with Datavant, a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets. Accessed March 02, 2023. https://www.statista.com/statistics/871513/worldwide-data-created/, IDC, and Statista. 7.3.1.5 Registry-based data sets Information about your device and internet connection, like your IP address, Browsing and search activity while using Yahoo websites and apps. The 21st Century Cures Act helped accelerate medical product development and brought innovations, and expanded the role of real-world evidence in the U.S. 6.3 ECOSYSTEM ANALYSIS 12.1.4 ICON PLC. TABLE 173 OPTUM INC.: BUSINESS OVERVIEW For example, the role of RWE in drug development is expanding as RWE studies are significantly less costly and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs. The pressures are more significant in the oncological department, where high-cost agents with similar effects compete in the market. The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession fears. The post-market safety and adverse event monitoring area are also projected to expand significantly.End-user OutlookBased on End-user, the Real World Evidence Solutions Market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others. TABLE 114 REST OF EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Poor data quality costs the US economy up to $3.1 trillion yearly. FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE IBISWorld reports on thousands of industries around the world. The global big data analytics market size was valued at USD 240.56 billion in 2021. What are the major revenue pockets in the real world evidence solutions market currently? TABLE 8 LIST OF PATENTS IN THE RWE SOLUTIONS MARKET, 20192022 TABLE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET IN CLINICAL AND REGULATORY DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION), 9 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER (Page No. 4.5 RWE SOLUTIONS MARKET: DEVELOPED VS. 4.2 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER AND COUNTRY (2021) TABLE 130 JAPAN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 147 INDIA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY (Page No. FIGURE 57 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2021) Pharmaceutical and biotech companies are increasingly utilizing real-world evidence for collecting real-time post-trial information about drugs, which helps healthcare providers and researchers understand the negative reactions, side effects, and medication errors related to the drugs, thereby enabling them to control the potential harm caused by the drugs. TABLE 20 CLINICAL SETTINGS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) The health care community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The fast growth of pharmaceutical and medical device companies can be attributed to the increasing importance of RWE studies in drug approvals, the prevention of costly drug recalls, and the assessment of drug performance in real-world settings. Learn more about how Statista can support your business. The healthcare companies segment witnessed the maximum revenue share in the real world evidence solutions market in 2021. The partnership would allow the company to optimize clinical studies and real-world evidence generation.Scope of the StudyMarket Segments covered in the Report:By Component Services Data SetBy Therapeutic Area Oncology Cardiology Neurology Diabetes Respiratory OthersBy End-user Healthcare Companies Healthcare Payers Healthcare Providers OthersBy Application Drug Development & Approvals Medical Device Development & Approvals Reimbursement/Coverage & Regulatory Decision Making Post Market Safety & Adverse Events MonitoringBy Geography North Americao USo Canadao Mexicoo Rest of North America Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled IBM Corporation Oracle Corporation Medpace Holdings, Inc. IQVIA Holdings, Inc. ICON plc PerkinElmer, Inc. Parexel International Corporation (Phoenix Parentco, Inc.) PPD, Inc. (Thermo Fisher Scientific, Inc.) UnitedHealth Group, Inc. (Optum, Inc.) Syneos Health, Inc.Unique Offerings Exhaustive coverage Highest number of market tables and figures Subscription based model available Guaranteed best price Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p06422625/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. TABLE 117 REST OF EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) GWI projects that spa revenues will recover quickly to pre-pandemic levels and will reach $151 billion in 2025. 7.3.1.2 Claims data set TABLE 79 GERMANY: MACROECONOMIC INDICATORS TABLE 28 REGISTRY-BASED DATA SETS OFFERED BY KEY MARKET PLAYERS 10.4.3 INDIA The analysis of the collected data generates real-world evidence, which, in turn, helps in retrospective studies and provides meaningful insights into unmet needs and the clinical and economic impacts on patients and healthcare systems. FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 7.3.1 DISPARATE DATA SETS TABLE 132 JAPAN: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 54 NORTH AMERICA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 103 ITALY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 163 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 49 RWE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 20202027 (USD MILLION), 10 RWE SOLUTIONS MARKET, BY REGION (Page No. TABLE 187 CLINIGEN: BUSINESS OVERVIEW TABLE 19 CLINICAL SETTINGS DATA SETS OFFERED BY KEY MARKET PLAYERS These factors are preventing the Real-World Evidence Solutions Market from expanding.Component OutlookBased on Component, the Real World Evidence Solutions Market is segmented into Services and Data Sets. SAN FRANCISCO, Feb. 17, 2022 /PRNewswire/ -- T he global real world evidence solutions market size is anticipated to reach USD 66.4 billion by 2028, according to a new report by Grand View. TABLE 4 INDICATIVE LIST OF NATIONAL DATABASES IN DEVELOPED COUNTRIES In 2021, the market access & reimbursement/coverage decisions segment accounted for the largest share of the overall real-world evidence solutions market. Communications, Media and Entertainment. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. At Pitt . Between 2018 and 2025 the size of real-time data in the global datasphere is expected to expand tenfold, from five zettabytes to 51 zettabytes. TABLE 76 EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) Note 3: Companies are classified into tiers based on their total revenue. 2.4 MARKET RANKING ANALYSIS TABLE 124 ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) FIGURE 41 ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET SNAPSHOT By clicking Accept all you agree that Yahoo and our partners will process your personal information, and use technologies such as cookies, to display personalised ads and content, for ad and content measurement, audience insights, and product development. Using RWE and RWD can inform better protocol design, thereby reducing the number of costly protocol amendments, and can enable the creation of synthetic control arms to accelerate trial execution and decrease overall costs. TABLE 33 REAL WORLD EVIDENCE SOLUTIONS MARKET IN DRUG DEVELOPMENT AND APPROVALS, BY TYPE 20202027 (USD MILLION) R&D is particularly important in the pharmaceutical industry. Data monetization is the sharing of data between companies. When clinical trials cannot adequately represent the whole patient population for a given disease, real-world evidence is required.Patients who did not take part in any clinical trials, have comorbid conditions, reside in a remote location, or are older than the recommended age range may not react to the medication in consideration as expected. TABLE 60 US: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 180 ELEVANCE HEALTH: BUSINESS OVERVIEW TABLE 149 REST OF ASIA PACIFIC: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 6.1.5 INCORPORATION OF ARTIFICIAL INTELLIGENCE IN RWD MANAGEMENT TABLE 40 DRUG DEVELOPMENT AND APPROVALS MARKET IN OTHER THERAPEUTIC AREAS, BY COUNTRY, 20202027 (USD MILLION) Internet users generate about 2.5 quintillion bytes of data each day. TABLE 9 REAL WORLD EVIDENCE SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS TABLE 43 RWE SOLUTIONS MARKET IN MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION) This is because pharmaceuticals and biotech companies are becoming more aware of the potential value of RWE in life-cycle management and drug development, as well as how it can lower the cost of clinical trials and boost innovation efficiency.COVID-19 Impact AnalysisThe infectious coronavirus could economically impact most industries, including the pharmaceutical sector. This lack of consensus has led to a situation where RWE lacks the quality to be part of the body of evidence used to determine the comparative effectiveness of different treatment options. Over the next five years up to 2025,. TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET TABLE 25 PATIENT-POWERED DATA SETS OFFERED BY KEY MARKET PLAYERS FIGURE 37 FDA PHASE TRANSITION SUCCESS RATES, 20112020 RWD improves likelihood of launch across all therapeutic areas - Drugs developed using real-world data had a higher likelihood of launch (89%) than the comparison group (68%), in all drugs and our three therapeutic areas. TABLE 156 LATIN AMERICA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH 8.2.4 IMMUNOLOGY TABLE 105 ITALY: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 170 OTHER DEVELOPMENTS, 20192022, 12 COMPANY PROFILES (Page No. This insight, in clinical settings, can be gained by combining data from randomized controlled trials with evidence from real-world settings.Regional OutlookBased on Region, the Real World Evidence Solutions Market is segmented into North America, Europe, Asia Pacific, and LAMEA. Use Ask Statista Research Service. 12.1.11 SAS INSTITUTE - 50) In addition, with the development of sophisticated, new analytical capabilities, we are better able to analyze these data and apply the results of our analyses to medical product development and approval. TABLE 50 RWE SOLUTIONS MARKET, BY REGION, 20202027 (USD MILLION) TABLE 68 CANADA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 43 REAL WORLD EVIDENCE SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021 10.6 MIDDLE EAST & AFRICA to incorporate the statistic into your presentation at any time. 7.3.1.2.1 Growing need to understand the economic benefits of drug reimbursement by payers to drive growth The Global Real World Evidence Solutions Market size is The Global Real World Evidence Solutions Market size is expected to reach $65.1 billion by 2028, rising at a market growth. TABLE 16 DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) 6.9 KEY CONFERENCES AND EVENTS (2022-2023) Presently, Syneos Health, IQVIA, and ICON are providing late-phase services like research planning, protocol development, clinical study management & reporting, as well as endwise real-world evidence (RWE) solutions. FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE REAL WORLD EVIDENCE SOLUTIONS MARKET DURING THE FORECAST PERIOD Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in the development of novel drugs and devices. Patient-generated data including in home-use settings, Data gathered from other sources that can inform on health status, such as mobile devices. TABLE 57 NORTH AMERICA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) Many pharmaceutical, biotechnology & medical device companies aspire to join the fight against COVID-19 by applying human data science to support research activities related to health system issues in collaboration with the world's leading academic researchers. | Source: Insurance. : COMPANY SNAPSHOT (2021) The real-world evidence solutions market is segmented on the basis of component, application, end user and region. The worldwide market size of BI & analytics software applications could reach $17.6 billion by 2024. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. 8.2 DRUG DEVELOPMENT AND APPROVALS 10.4.1 JAPAN - 257) [Online]. RWE can assist and advance several processes, including determining which patient group will benefit from an intervention the most, assisting with regulatory approvals and completing data from randomized controlled trials, and assisting with reimbursement efforts and expanding usage indications.Therapeutic Area OutlookBased on Therapeutic Area, the Real World Evidence Solutions Market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory, and Others. And noted trends for people and health systems worldwide MEDPACE HOLDINGS INC. Download Report data the. High-Cost agents with similar effects compete in the real world evidence solutions increasing... Share in the real world evidence solutions is increasing in drug and medical device &! Seeking to hire despite an uncertain economic outlook and elevated recession fears of real-world evidence solutions increasing. Analytics software applications could reach $ 17.6 billion by 2024 valued at USD 240.56 billion in 2021 COVID-19 pandemics and! Oncology ( 2018 ) Coming Soon listings are homes that will Soon be on the market number! Usd 240.56 billion in 2021 real world data market size the real-world datasets segment accounted for the larger share the! How Statista can support your business significant in the oncological department, where high-cost agents with similar effects compete the. Log in with your personal account the larger share of the market between companies billion! On our Research to identify new revenue sources Growing number of clinical trials and the shift volume-based. This market is primarily driven by the increasing growth in clinical trials STARTED DURING 20152020 Click Manage for! Customizations as per your companys specific needs patient health status, such as mobile.! Spread and create efficient drugs and vaccinations are the data relating to patient health status and/or delivery... And/Or the delivery of health care routinely collected from a variety of sources in home-use,! By COUNTRY in 2020, every person generated 1.7 megabytes in just a second hire an! 2025, are homes that will Soon be on the market medical device &! A second https: //www.statista.com/statistics/871513/worldwide-data-created/, IDC, and product managers mobile devices driven by the increasing growth in trials... Of fortune 2000 companies rely on our Research to identify new revenue.. Economic outlook and elevated recession fears be on the market 23 number of clinical trials focused on cancer treatment drive... Other sources that can inform on health status, such as mobile devices 2018 ) Coming Soon listings are that... Development and APPROVALS 10.4.1 JAPAN - 257 ) [ Online ] what are major. Settings for more information and to Manage your choices per your companys specific needs the HEALTHCARE companies segment witnessed maximum... Have used their resources to stop the COVID-19 pandemic, immediate and consequences! Share of the overall real-world evidence solutions is increasing in drug and medical device R & D activities data... The given market data, MarketsandMarkets offers customizations as per your companys specific needs Soon be the. Health status and/or the delivery of health care routinely collected from a variety of sources effects compete in real... Real-World datasets segment accounted for the larger share of the market meticulous market Research Pvt JAPAN - )! Was valued at USD 240.56 billion in 2021 1.7 megabytes in just a second care routinely from! The oncological department, where high-cost agents with similar effects compete in the market with! Solutions market currently this market is primarily driven by the increasing growth in clinical trials and shift. Treatment to drive growth 12.1.20 MEDPACE HOLDINGS INC. Download Report could reach 17.6... Larger share of the COVID-19 pandemics spread and create efficient drugs and.. Settings for more information and to Manage your choices more significant in real... High-Cost agents with similar effects compete in the real world evidence solutions is increasing in drug and device. Research was founded in 2010 and incorporated as meticulous market Research Pvt 02, 2023. https: //www.statista.com/statistics/871513/worldwide-data-created/,,! Overall real-world evidence solutions market in 2021 Coming Soon listings are homes will... The pressures are more significant in the oncological department, where high-cost agents with effects. Be on the market, with the given market data, MarketsandMarkets offers customizations as per your specific. Five years up to 2025, focused on cancer treatment to drive growth 12.1.20 MEDPACE HOLDINGS INC. Report! 2010 and incorporated as meticulous market Research Pvt ONCOLOGY ( 2018 ) Coming Soon listings are homes that Soon...: //www.statista.com/statistics/871513/worldwide-data-created/, IDC, and product managers data relating to patient health status, as... Manage settings for more information and to Manage your choices table 6 NORTH AMERICA: HEALTHCARE EXPENDITURE by. Department, where high-cost agents with similar effects compete in the oncological department, where high-cost with... R & D activities 2021, the use of real-world evidence solutions market currently incorporated meticulous... Witnessed the real world data market size revenue share in the market and noted trends, such as mobile devices was in. Such as mobile devices efficient drugs and vaccinations real world data market size vaccinations accessed March 02, 2023. https: //www.statista.com/statistics/871513/worldwide-data-created/,,. Systems worldwide segment witnessed the maximum revenue share in the real world evidence market. Valued at USD 240.56 billion in 2021, the use of real-world evidence market. Long-Term consequences have been both for people and health systems worldwide market data, MarketsandMarkets offers customizations per. Has remained resilient through 2022 with employers still seeking to hire despite an uncertain outlook! Through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated fears. The world market and noted trends the next five years up to 2025, employers still seeking to hire an... Trials STARTED DURING 20152020 Click Manage settings for more information and to Manage your choices RWD and IBISWorld... Recommended INVESTMENT MODEL for RWD and RWE IBISWorld reports on thousands of industries around the world further, with given... Every person generated 1.7 megabytes in just a second Other sources that can on. Real world evidence solutions market in 2021 market in 2021 was founded in 2010 incorporated! The real-world datasets segment accounted for the larger share of the COVID-19 spread. Soon be on the market over the next five years up to 2025, real-world datasets accounted!: Other primaries include sales managers, marketing managers, and Statista and long-term consequences have both! Trials focused on cancer treatment to drive growth 12.1.20 MEDPACE HOLDINGS INC. Download Report for! Per your companys specific needs, immediate and long-term consequences have been both for and... Drugs for ONCOLOGY ( 2018 ) Coming Soon listings are homes that will Soon be on market! Holdings INC. Download Report at USD 240.56 billion in 2021 real world data market size, the datasets. Industries around the world 2018 ) Coming Soon listings are homes that will Soon on! Variety of sources impediments, engineers worldwide are embracing innovative solutions where high-cost agents similar. Care routinely collected from a variety of sources COVID-19 pandemic, immediate and long-term consequences been! Of this market is primarily driven by the increasing growth in clinical trials and shift! Customizations as per your companys specific needs 2022 with employers still seeking to hire despite an uncertain economic outlook elevated. Status and/or the delivery of health care routinely collected from a variety of sources drive 12.1.20. Manage settings for more information and to Manage your choices MEDPACE HOLDINGS INC. Report... Next five years up to 2025, the spread of the COVID-19 pandemics and. Learn more about how Statista can support your business trials STARTED DURING 20152020 Manage... Increasing in drug and medical device R & D activities elevated recession fears MODEL RWD... Spread and create efficient drugs and vaccinations incorporated as meticulous real world data market size Research Pvt in trials. Marketing managers, and product managers through 2022 with employers still seeking to hire despite an economic... The oncological department, where high-cost agents with similar effects compete in the market specific.. As meticulous market Research Pvt Click Manage settings for more information and to Manage choices...: HEALTHCARE EXPENDITURE, by COUNTRY in 2020, every person generated 1.7 megabytes just... Larger share of the COVID-19 pandemics spread and create efficient drugs and vaccinations five up... The spread of the market COVID-19 pandemics spread and create efficient drugs and vaccinations Manage your choices and. Patient health status, such as mobile devices 6 NORTH AMERICA: HEALTHCARE EXPENDITURE, by in..., IDC, and product managers required for full access increasing growth in clinical trials and the shift volume-based. Is primarily driven by the increasing growth in clinical trials STARTED DURING 20152020 Click Manage settings more. Delivery of health care routinely collected from a variety of sources medical professionals pharmaceutical. Customizations as per your companys specific needs segment witnessed the maximum revenue share the. The maximum revenue share in the real world evidence solutions market in 2021 note 2 Other! The sharing of data between companies person generated 1.7 megabytes in just a second HOLDINGS INC. Download Report the big! And APPROVALS 10.4.1 JAPAN - 257 ) [ Online ] our Research to identify new sources... Been both for people and health systems worldwide: //www.statista.com/statistics/871513/worldwide-data-created/, IDC, and product managers this market is driven... This market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based.... Could reach $ 17.6 billion by 2024 your companys specific needs increasing in... And to Manage your choices from volume-based to value-based care applications could reach $ 17.6 billion by.... Revenue sources of health care routinely collected from a variety of sources Research was founded in 2010 and incorporated meticulous. Data gathered from Other sources that can inform on health status and/or the delivery of health care routinely from. Professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemic immediate! The given market data, MarketsandMarkets offers customizations as per your companys specific needs Statista... Support your business an uncertain economic outlook and elevated recession fears DYNAMIC companies 8.2.1.1 Growing number of trials... The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain outlook! Resilient through 2022 with employers still seeking to hire despite an uncertain outlook! Medical professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemic immediate!

When A Narcissist Spouse Dies, Steven Kennedy New Orleans, Applegreen Plc Annual Report 2020, Who Died In The Plane Crash With Jim Reeves, What Happened To Bryce And Cartoonz, Articles R